The international society for supportive care in cancer, whose antiemetic, mucositis, febrile neutropenia and immunotherapy toxicity guidelines are used worldwide.
Founded in 1990, MASCC is a multidisciplinary organisation of physicians, nurses, pharmacists and other professionals dedicated to preventing and managing the side effects of cancer and its treatment. Its MASCC/ESMO antiemetic guidelines, the MASCC risk index for febrile neutropenia, mucositis guidelines with ISOO, and guidance on bone health, skin toxicity, cancer-related fatigue, immunotherapy toxicities and survivorship are widely adopted, and it publishes Supportive Care in Cancer. The MASCC annual meeting brings together supportive care researchers with the palliative care and oncology societies, and its study groups cover nutrition and cachexia, geriatrics, psychosocial care, oral care, neurological complications and palliative care.
Shares Honey for radiation mucositis, Glutamine for mucositis and neuropathy, Oral cryotherapy (ice chips) to prevent mucositis, Photobiomodulation (low-level laser) for oral mucositis.
Shares Scalp cooling (cold caps: DigniCap, Paxman), Cardio-oncology, Cachexia, toxicity and the limits of the patient, Geriatric assessment.
Shares Honey for radiation mucositis, Glutamine for mucositis and neuropathy, Oral cryotherapy (ice chips) to prevent mucositis, Photobiomodulation (low-level laser) for oral mucositis.
Shares Supportive care in cancer, Photobiomodulation (low-level laser) for oral mucositis.
Shares Cachexia, toxicity and the limits of the patient, Geriatric assessment, Exercise & lifestyle oncology, Toxicity and quality of life are undervalued.
Shares Geriatric assessment, Exercise & lifestyle oncology, Older and multimorbid patients are excluded and undertreated, Toxicity and quality of life are undervalued.
Shares Cachexia, toxicity and the limits of the patient, Geriatric assessment, Exercise & lifestyle oncology, Toxicity and quality of life are undervalued.
Shares Geriatric assessment, Exercise & lifestyle oncology, Older and multimorbid patients are excluded and undertreated, Toxicity and quality of life are undervalued.